标题
Polymorphism of human cytochrome P450 enzymes and its clinical impact
作者
关键词
-
出版物
DRUG METABOLISM REVIEWS
Volume 41, Issue 2, Pages 89-295
出版商
Informa UK Limited
发表日期
2009-05-07
DOI
10.1080/03602530902843483
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacogenetics of Tamoxifen: Who Should UndergoCYP2D6Genetic Testing?
- (2017) Michaela J. Higgins et al. Journal of the National Comprehensive Cancer Network
- Role of CYP2B6 in Stereoselective Human Methadone Metabolism
- (2009) Rheem A. Totah et al. ANESTHESIOLOGY
- Two Novel CYP2D6*10 Haplotypes As Possible Causes of a Poor Metabolic Phenotype in Japanese
- (2009) M. Matsunaga et al. DRUG METABOLISM AND DISPOSITION
- Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
- (2009) David A Flockhart et al. GENETICS IN MEDICINE
- Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol
- (2009) Julia Kirchheiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- CYP2D6 Polymorphism in Relation to Tramadol Metabolism: A Study of Faroese Patients
- (2009) Jónrit Halling et al. THERAPEUTIC DRUG MONITORING
- Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole
- (2009) Ragnhild Birkeland Waade et al. THERAPEUTIC DRUG MONITORING
- Clinical profile of prasugrel, a novel thienopyridine
- (2008) Dominick J. Angiolillo et al. AMERICAN HEART JOURNAL
- Prasugrel: A novel antiplatelet agent
- (2008) A. B. Riley et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
- (2008) Y. Xu et al. ANNALS OF ONCOLOGY
- Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients
- (2008) Jung-Ryul Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians
- (2008) Nicole G. Hunfeld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants
- (2008) Monique J. Bijl et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa
- (2008) Corine Ekhart et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphisms in Genes Involved in Sex Hormone Metabolism, Estrogen Plus Progestin Hormone Therapy Use, and Risk of Postmenopausal Breast Cancer
- (2008) B. Diergaarde et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- (2008) Ken-ichi Fujita et al. CANCER SCIENCE
- Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- Stereoselective Disposition of Proton??Pump Inhibitors
- (2008) Tommy Andersson et al. CLINICAL DRUG INVESTIGATION
- CYP2D6 Phenotype Prediction From Genotype: Which System Is the Best?
- (2008) J Kirchheiner CLINICAL PHARMACOLOGY & THERAPEUTICS
- The CYP3A4*18 Genotype in the Cytochrome P450 3A4 Gene, a Rapid Metabolizer of Sex Steroids, Is Associated With Low Bone Mineral Density
- (2008) YS Kang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study
- (2008) P Madadi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacology of Nicotine: Implications for Understanding, Preventing, and Treating Tobacco Addiction
- (2008) NL Benowitz CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
- (2008) MJ Bijl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics and Potential Application in Personalized Medicine
- (2008) Shu-Feng Zhou et al. CURRENT DRUG METABOLISM
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
- Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions
- (2008) Liana Urichuk et al. CURRENT DRUG METABOLISM
- Type 2 Diabetes and Oral Antihyperglycemic Drugs
- (2008) Mitchell Avery et al. CURRENT MEDICINAL CHEMISTRY
- Erhöhte Flecainid-Plasmakonzentrationen bei Herzinsuffizienz*
- (2008) J. Nitsch et al. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
- In Vitro Metabolism of 2-[6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] Acetic Acid (Licofelone, ML3000), an Inhibitor of Cyclooxygenase-1 and -2 and 5-Lipoxygenase
- (2008) W. Albrecht et al. DRUG METABOLISM AND DISPOSITION
- Characterization of CYP2A13*2, a Variant Cytochrome P450 Allele Previously Found to Be Associated with Decreased Incidences of Lung Adenocarcinoma in Smokers
- (2008) J. D'Agostino et al. DRUG METABOLISM AND DISPOSITION
- An in Vitro Mechanistic Study to Elucidate the Desipramine/Bupropion Clinical Drug-Drug Interaction
- (2008) M. J. Reese et al. DRUG METABOLISM AND DISPOSITION
- Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes
- (2008) W.-Y. Zhang et al. DRUG METABOLISM AND DISPOSITION
- Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)
- (2008) K. Sakuyama et al. DRUG METABOLISM AND DISPOSITION
- Role of Flavin-Containing Monooxygenase in Oxidative Metabolism of Voriconazole by Human Liver Microsomes
- (2008) S. B. Yanni et al. DRUG METABOLISM AND DISPOSITION
- Generation of Mice Transgenic for Human CYP2C18 and CYP2C19: Characterization of the Sexually Dimorphic Gene and Enzyme Expression
- (2008) S. Lofgren et al. DRUG METABOLISM AND DISPOSITION
- The Biotransformation of Prasugrel, a New Thienopyridine Prodrug, by the Human Carboxylesterases 1 and 2
- (2008) E. T. Williams et al. DRUG METABOLISM AND DISPOSITION
- Bupropion
- (2008) Sohita Dhillon et al. DRUGS
- Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements
- (2008) Andrea Gaedigk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele
- (2008) M. Hermann et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Chronic heart failure: β-blockers and pharmacogenetics
- (2008) Junichi Azuma et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individual
- (2008) Andrea Gaedigk et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pantoprazole: from drug metabolism to clinical relevance
- (2008) Marc Bardou et al. Expert Opinion on Drug Metabolism & Toxicology
- Maternal cigarette smoking, metabolic gene polymorphisms, and preterm delivery: new insights on G×E interactions and pathogenic pathways
- (2008) Hui-Ju Tsai et al. HUMAN GENETICS
- Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent
- (2008) Jill C. Mwenifumbo et al. HUMAN MUTATION
- Genetic Variations of CYP2C9 in 724 Japanese Individuals and Their Impact on the Antihypertensive Effects of Losartan
- (2008) Tong YIN et al. HYPERTENSION RESEARCH
- Antiretroviral Treatment of Adult HIV Infection
- (2008) Scott M. Hammer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities
- (2008) Rixt F. Riemersma-van der Lek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
- (2008) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects WithCYP1A2g.-163C>A Polymorphism
- (2008) Johanna Hilli et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity
- (2008) Evan D. Kharasch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver
- (2008) M. H. Hofmann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)
- (2008) T. Erkinjuntti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities
- (2008) A. L. FRELINGER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel CYP2C9 Promoter Variants and Assessment of Their Impact on Gene Expression
- (2008) M. A. Kramer et al. MOLECULAR PHARMACOLOGY
- Chemotherapy-Induced Nausea and Vomiting
- (2008) Paul J. Hesketh NEW ENGLAND JOURNAL OF MEDICINE
- Genetic polymorphisms of CYP2A6 affect the in-vivo pharmacokinetics of pilocarpine
- (2008) Takuro Endo et al. Pharmacogenetics and Genomics
- A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent
- (2008) Man Ki Ho et al. Pharmacogenetics and Genomics
- Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide
- (2008) Corine Ekhart et al. Pharmacogenetics and Genomics
- Impact of genetic polymorphisms inCYP2C8and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
- (2008) Julia Kirchheiner et al. PHARMACOGENOMICS
- Impact ofCYP2C19polymorphisms on the efficacy of clobazam therapy
- (2008) Takayuki Seo et al. PHARMACOGENOMICS
- CYP2A6polymorphisms and risk for tobacco-related cancers
- (2008) Ana Rossini et al. PHARMACOGENOMICS
- Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms
- (2008) Arzu Gunes et al. PHARMACOGENOMICS
- Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China
- (2008) Lingling Chen et al. PHARMACOGENOMICS
- Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity
- (2008) Adrián LLerena et al. PHARMACOGENOMICS
- Genetic Testing for Warfarin Dosing? Not Yet Ready for Prime Time
- (2008) Henry I Bussey et al. PHARMACOTHERAPY
- The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses
- (2008) Heather M. Judge et al. PLATELETS
- Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
- (2008) Eric J. Peters et al. PLoS One
- Protective Interventions to Prevent Aflatoxin-Induced Carcinogenesis in Developing Countries
- (2007) John D. Groopman et al. Annual Review of Public Health
- Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype
- (2007) H. J. M. van Kan et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population
- (2007) Jónrit Halling et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Potential Mechanisms of Estrogen Quinone Carcinogenesis
- (2007) Judy L. Bolton et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly Inhibits Cytochrome P450 2B6 in Humans
- (2007) Nag A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation
- (2007) Hiro-o Yamano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis
- (2007) Xiuquan Shi et al. LUNG CANCER
- Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine
- (2003) Ole V. Olesen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Involvement of human liver cytochrome P4502B6in the metabolism of propofol
- (2003) Yutaka Oda et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started